RGBP 2.00 Regen BioPharma, Inc.
| Range: | 0.1152-1.88 | Vol Avg: | 9985 | Last Div: | 0 | Changes: | 0.05 |
| Beta: | 2.99 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Mon Oct 06 2014 | Empoloyees: | 1 | ||
| CUSIP: | 75886M102 | CIK: | 0001589150 | ISIN: | US75886M3007 | Country: | US |
| CEO: | Dr. David Raymond Koos DBA, Ph.D. | Website: | https://www.regenbiopharmainc.com | ||||
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow